Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:784-789
doi: 10.1161/01.CIR.0000112575.66565.84
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oyama, J.-i.
Right arrow Articles by Bourcier, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oyama, J.-i.
Right arrow Articles by Bourcier, T.
Related Collections
Right arrow Animal models of human disease
Right arrow Growth factors/cytokines
Right arrow Ischemic biology - basic studies
Right arrow Acute myocardial infarction

(Circulation. 2004;109:784-789.)
© 2004 American Heart Association, Inc.


Basic Science Reports

Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice

Jun-ichi Oyama, MD; Charles Blais, Jr, PhD; Xiaoli Liu, MD; Minying Pu, MD; Lester Kobzik, MD; Ralph A. Kelly, MD; Todd Bourcier, PhD

From the Department of Cardiovascular Medicine (J.O., C.B., M.P.); Pulmonary and Critical Care Division (X.L.); Anesthesiology, Perioperative and Pain Medicine (T.B.), Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women’s Hospital, Boston; Department of Pathology (L.K.), Harvard Medical School, Boston; and Genzyme Corporation (R.A.K.), Framingham, Mass.

Correspondence to Todd Bourcier, PhD, Department of Anesthesiology, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Brigham & Women’s Hospital, Medical Research Building #502, Boston, MA 02115. E-mail tbourcier{at}rics.bwh.harvard.edu

Received January 14, 2003; de novo received July 14, 2003; revision received October 2, 2003; accepted October 6, 2003.

Background— Myocardial ischemia and reperfusion-induced tissue injury involve a robust inflammatory response, but the proximal events in reperfusion injury remain incompletely defined. Toll-like receptor 4 (TLR4) is a proximal signaling receptor in innate immune responses to lipopolysaccharide of Gram-negative pathogens. TLR4 is also expressed in the heart and vasculature, but a role for TLR4 in the myocardial response to injury separate from microbial pathogens has not been examined. This study assessed the role of TLR4 in myocardial infarction and inflammation in a murine model of ischemia-reperfusion injury.

Methods and Results— Myocardial ischemia-reperfusion (MIR) was performed on 2 strains of TLR4-deficient mice (C57/BL10 ScCr and C3H/HeJ) and controls (C57/BL10 ScSn and C3H/OuJ). Mice were subjected to 1 hour of coronary ligation, followed by 24 hours of reperfusion. TLR4-deficient mice sustained significantly smaller infarctions compared with control mice given similar areas at risk. Fewer neutrophils infiltrated the myocardium of TLR4-deficient Cr mice after MIR, indicated by less myeloperoxidase activity and fewer CD45/GR1-positive cells. The myocardium of TLR4-deficient Cr mice contained fewer lipid peroxides and less complement deposition compared with control mice after MIR. Serum levels of interleukin-12, interferon-{gamma}, and endotoxin were not increased after ischemia-reperfusion. Neutrophil trafficking in the peritoneum was similar in all strains after injection of thioglycollate.

Conclusions— TLR4-deficient mice sustain smaller infarctions and exhibit less inflammation after myocardial ischemia-reperfusion injury. The data suggest that in addition to its role in innate immune responses, TLR4 serves a proinflammatory role in murine myocardial ischemia-reperfusion injury.


Key Words: inflammation • myocardial infarction • ischemia




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
A. Yoshizaki, Y. Iwata, K. Komura, F. Ogawa, T. Hara, E. Muroi, M. Takenaka, K. Shimizu, M. Hasegawa, M. Fujimoto, et al.
CD19 Regulates Skin and Lung Fibrosis via Toll-Like Receptor Signaling in a Model of Bleomycin-Induced Scleroderma
Am. J. Pathol., June 1, 2008; 172(6): 1650 - 1663.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Ha, F. Hua, X. Liu, J. Ma, J. R. McMullen, T. Shioi, S. Izumo, J. Kelley, X. Gao, W. Browder, et al.
Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism
Cardiovasc Res, June 1, 2008; 78(3): 546 - 553.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Riad, S. Jager, M. Sobirey, F. Escher, A. Yaulema-Riss, D. Westermann, A. Karatas, M. M. Heimesaat, S. Bereswill, D. Dragun, et al.
Toll-Like Receptor-4 Modulates Survival by Induction of Left Ventricular Remodeling after Myocardial Infarction in Mice
J. Immunol., May 15, 2008; 180(10): 6954 - 6961.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Cha, Z. Wang, L. Ao, N. Zou, C. A. Dinarello, A. Banerjee, D. A. Fullerton, and X. Meng
Cytokines link toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia.
Ann. Thorac. Surg., May 1, 2008; 85(5): 1678 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. P. van der Kaaij and A. J.J.C. Bogers
Invited commentary.
Ann. Thorac. Surg., May 1, 2008; 85(5): 1685 - 1685.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Zhang, G. Ramesh, S. Uematsu, S. Akira, and W. B. Reeves
TLR4 Signaling Mediates Inflammation and Tissue Injury in Nephrotoxicity
J. Am. Soc. Nephrol., May 1, 2008; 19(5): 923 - 932.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. J. Kaczorowski, K. P. Mollen, R. Edmonds, and T. R. Billiar
Early events in the recognition of danger signals after tissue injury
J. Leukoc. Biol., March 1, 2008; 83(3): 546 - 552.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Timmers, J. P.G. Sluijter, J. K. van Keulen, I. E. Hoefer, M. G.J. Nederhoff, M.-J. Goumans, P. A. Doevendans, C. J.A. van Echteld, J. A. Joles, P. H. Quax, et al.
Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction
Circ. Res., February 1, 2008; 102(2): 257 - 264.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. P. Mollen, R. M. Levy, J. M. Prince, R. A. Hoffman, M. J. Scott, D. J. Kaczorowski, R. Vallabhaneni, Y. Vodovotz, and T. R. Billiar
Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells
J. Leukoc. Biol., January 1, 2008; 83(1): 80 - 88.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Tsung, J. R. Klune, X. Zhang, G. Jeyabalan, Z. Cao, X. Peng, D. B. Stolz, D. A. Geller, M. R. Rosengart, and T. R. Billiar
HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling
J. Exp. Med., November 26, 2007; 204(12): 2913 - 2923.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. L. Leaphart, J. Cavallo, S. C. Gribar, S. Cetin, J. Li, M. F. Branca, T. D. Dubowski, C. P. Sodhi, and D. J. Hackam
A Critical Role for TLR4 in the Pathogenesis of Necrotizing Enterocolitis by Modulating Intestinal Injury and Repair
J. Immunol., October 1, 2007; 179(7): 4808 - 4820.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. M. Levy, K. P. Mollen, J. M. Prince, D. J. Kaczorowski, R. Vallabhaneni, S. Liu, K. J. Tracey, M. T. Lotze, D. J. Hackam, M. P. Fink, et al.
Systemic inflammation and remote organ injury following trauma require HMGB1
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1538 - R1544.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Goldberg, M. Parolini, B. Y. Chin, E. Czismadia, L. E. Otterbein, F. H. Bach, and H. Wang
Toll-like receptor 4 suppression leads to islet allograft survival
FASEB J, September 1, 2007; 21(11): 2840 - 2848.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Divanovic, A. Trompette, L. K. Petiniot, J. L. Allen, L. M. Flick, Y. Belkaid, R. Madan, J. J. Haky, and C. L. Karp
Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105
J. Leukoc. Biol., August 1, 2007; 82(2): 265 - 271.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. T. Figueiredo, P. L. Fernandez, D. S. Mourao-Sa, B. N. Porto, F. F. Dutra, L. S. Alves, M. F. Oliveira, P. L. Oliveira, A. V. Graca-Souza, and M. T. Bozza
Characterization of Heme as Activator of Toll-like Receptor 4
J. Biol. Chem., July 13, 2007; 282(28): 20221 - 20229.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
U. Koedel, U. M. Merbt, C. Schmidt, B. Angele, B. Popp, H. Wagner, H.-W. Pfister, and C. J. Kirschning
Acute Brain Injury Triggers MyD88-Dependent, TLR2/4-Independent Inflammatory Responses
Am. J. Pathol., July 1, 2007; 171(1): 200 - 213.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Hua, T. Ha, J. Ma, Y. Li, J. Kelley, X. Gao, I. W. Browder, R. L. Kao, D. L. Williams, and C. Li
Protection against Myocardial Ischemia/Reperfusion Injury in TLR4-Deficient Mice Is Mediated through a Phosphoinositide 3-Kinase-Dependent Mechanism
J. Immunol., June 1, 2007; 178(11): 7317 - 7324.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. R. Caso, J. M. Pradillo, O. Hurtado, P. Lorenzo, M. A. Moro, and I. Lizasoain
Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke
Circulation, March 27, 2007; 115(12): 1599 - 1608.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Shimamoto, T. H. Pohlman, S. Shomura, T. Tarukawa, M. Takao, and H. Shimpo
Toll-Like Receptor 4 Mediates Lung Ischemia-Reperfusion Injury
Ann. Thorac. Surg., December 1, 2006; 82(6): 2017 - 2023.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. E. Walker, I. W. Nasr, G. Camirand, B. M. Tesar, C. J. Booth, and D. R. Goldstein
Absence of Innate MyD88 Signaling Promotes Inducible Allograft Acceptance
J. Immunol., October 15, 2006; 177(8): 5307 - 5316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. M. Levy, J. M. Prince, R. Yang, K. P. Mollen, H. Liao, G. A. Watson, M. P. Fink, Y. Vodovotz, and T. R. Billiar
Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R970 - R976.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Zhu, H. Zhao, A. R. Graveline, E. S. Buys, U. Schmidt, K. D. Bloch, A. Rosenzweig, and W. Chao
MyD88 and NOS2 are essential for Toll-like receptor 4-mediated survival effect in cardiomyocytes
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1900 - H1909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Ha, F. Hua, D. Grant, Y. Xia, J. Ma, X. Gao, J. Kelley, D. L. Williams, J. Kalbfleisch, I. W. Browder, et al.
Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1910 - H1918.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Tada, Y. Kagaya, M. Takeda, J. Ohta, Y. Asaumi, K. Satoh, K. Ito, A. Karibe, K. Shirato, N. Minegishi, et al.
Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion
Cardiovasc Res, August 1, 2006; 71(3): 466 - 477.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
I. Jou, J. H. Lee, S. Y. Park, H. J. Yoon, E.-H. Joe, and E. J. Park
Gangliosides Trigger Inflammatory Responses via TLR4 in Brain Glia
Am. J. Pathol., May 1, 2006; 168(5): 1619 - 1630.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Tsung, R. A. Hoffman, K. Izuishi, N. D. Critchlow, A. Nakao, M. H. Chan, M. T. Lotze, D. A. Geller, and T. R. Billiar
Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells
J. Immunol., December 1, 2005; 175(11): 7661 - 7668.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Ha, Y. Li, F. Hua, J. Ma, X. Gao, J. Kelley, A. Zhao, G. E. Haddad, D. L. Williams, I. William Browder, et al.
Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload
Cardiovasc Res, November 1, 2005; 68(2): 224 - 234.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Chao, Y. Shen, X. Zhu, H. Zhao, M. Novikov, U. Schmidt, and A. Rosenzweig
Lipopolysaccharide Improves Cardiomyocyte Survival and Function after Serum Deprivation
J. Biol. Chem., June 10, 2005; 280(23): 21997 - 22005.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. D. Filippo, R. Marfella, S. Cuzzocrea, E. Piegari, P. Petronella, D. Giugliano, F. Rossi, and M. D'Amico
Hyperglycemia in Streptozotocin-Induced Diabetic Rat Increases Infarct Size Associated With Low Levels of Myocardial HO-1 During Ischemia/Reperfusion
Diabetes, March 1, 2005; 54(3): 803 - 810.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. W. Binck, M. F. Tsen, M. Islas, D. J. White, R. A. Schultz, M. S. Willis, J. V. Garcia, J. W. Horton, and J. A. Thomas
Bone marrow-derived cells contribute to contractile dysfunction in endotoxic shock
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H577 - H583.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhai, X.-d. Shen, R. O'Connell, F. Gao, C. Lassman, R. W. Busuttil, G. Cheng, and J. W. Kupiec-Weglinski
Cutting Edge: TLR4 Activation Mediates Liver Ischemia/Reperfusion Inflammatory Response via IFN Regulatory Factor 3-Dependent MyD88-Independent Pathway
J. Immunol., December 15, 2004; 173(12): 7115 - 7119.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. L. Stoll, G. M. Denning, and N. L. Weintraub
Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2227 - 2236.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
I. E. Konstantinov, S. Arab, R. K. Kharbanda, J. Li, M. M. H. Cheung, V. Cherepanov, G. P. Downey, P. P. Liu, E. Cukerman, J. G. Coles, et al.
The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans
Physiol Genomics, September 16, 2004; 19(1): 143 - 150.
[Abstract] [Full Text] [PDF]